Lux Capital Management was founded in 2000 by Josh Wolfe, Peter Hebert and Rob Paull. It is headquartered in New York, New York with additional offices in Menlo Park, California and San Diego, California. It is a venture capital firm specialising in investments in seed, early stage investments, special situations, and corporate spinouts in areas of energy, life sciences, biopharmaceutical, healthcare and technology. In addition to seeking to be a first institutional investor in its portfolio companies, it also provides follow on funding for future financing rounds. Lux Capital is headquartered in New York with an additional office in Menlo Park and San Diego California.
The company seeks to invest in emerging technologies in areas of advances materials, drug delivery, therapeutics, mobile health, novel materials, energy technology, wireless, semiconductors, nanotechnology and biotechnology sectors. The firm also invests in machine learning, artificial intelligence, 3D printing, meta materials, robotics and solid-state electronics. Life science areas include augmented reality for the blind, neurostimulation, age extending blood transplants, synthetic biology for industry and Internet of things security for industrial and factory automation.
The firm invests in energy, life sciences, biopharmaceutical, healthcare, and technology. It also invests in emerging technologies with a focus on advanced materials, drug delivery, energy technology, nanotechnology, alternative energy technologies, and biotechnology sectors. It also invests in augmented reality for the blind, neuro-stimulation and age extending blood transplants. The firm invests between $0.1 million in companies and invests up to $20 million in a startup.
Lux Capital has raised a total of $1.1 billion across 5 funds, their latest being Lux Capital Co-Investment Fund.
February 1, 2007
Lux Ventures II
February 10, 2015
Lux Ventures IV
February 13, 2013
Lux Ventures III
February 28, 2017
Lux Ventures V
November 30, 2017
Lux Capital Co-Investment Fund
Co-founded by creators of the Uber Michelangelo feature store, Tecton is a San Francisco-based company which enables data scientists to build a library of features and serve them in production.
A company developing antibody-based biological medicines for kidney diseases and other chronic diseases. Visterra was acquired by Otsuka Pharmaceutical in 2018.
A biotechnology and data science company based in Salt Lake City, Utah, founded in 2013, that combines biology with artificial intelligence for drug discovery. Using human cell models of diseases, Recursion captures microscopic images to build biological datasets and computational techniques identify disease-associated biological changes.
A synthetic biology company that designs, builds and tests genetic circuits for the purposes programming cell therapies. Their first therapeutic candidates are aimed at solid tumors and blood cancer and the company plans to move beyond oncology.
Echodyne is a company developing compact, solid-state, high-performance radar system founded in 2014.
Blockstack is a full stack internet platform for building decentralized apps.
Air Map is a drone industry company improving low-altitude-airspace infrastructure to help drone operators can fly safely and legally.
A biopharmaceutical company that develops nanotherapeutic treatments for ocular diseases and other eye related conditions
U.S-based 3D media technology company providing worldwide end-to-end virtual media solutions.
Company developing a machine learning platform for creating real-time special visual effects during live video capture
Halo Neuroscience develops devices that use neurostimulation technology to target the brain to enhance performance for able and impaired users.
A company that developed nano-imprint lithography systems.
A biopharmaceutical company developing T cell vaccines and immunotherapies
Benchling is a company based in San Francisco focusing on life science collaboration, both private and public, through creating cloud based software tools for digital DNA sequence editing, designing and running experiments, analyzing data, and sharing research.
Company developing and licensing Neural Inferencing Semiconductor IP/Software and embedded FPGA hard IP and software for reconfigurable RTL in SOCs, MCUs and other ICs
Synthetic biology company that uses AI, DNA synthesis, and robotics to discover biological molecules.
Primer is a San Francisco-based company founded in 2015 by Sean Gourley developing AI to generate written intelligence reports.
Statespace is an artificial Intelligence company founded in 2017 by Jay Fuller and Wayne Mackey.
Associated investment funds
Co-Founder and Managing Partner
Paolo Messina, PhD, MBA
Co-Founder and Managing Partner
R. James Woolsey
Co-Founder and Venture Partner
Scientist in Residence
Chief Financial Officer
Chief Operating Officer